Quantinuum (NASDAQ:QNT) Hits New 52-Week Low - Should You Sell?

Quantinuum logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Quantinuum hit a new 52-week low of $27.30 on Friday, below its previous close of $27.96.
  • Analyst views are mixed, but the consensus rating is “Moderate Buy” with an average price target of $80.21; ratings range from Sell to Buy.
  • For its latest quarter, Quantinuum reported a loss of $0.29 per share, narrower than the $0.99 loss analysts expected, on revenue of $9.05 million.
  • Interested in Quantinuum? Here are five stocks we like better.

Quantinuum Inc. (NASDAQ:QNT - Get Free Report)'s share price reached a new 52-week low during trading on Friday. The stock traded as low as $27.30 and last traded at $27.30, with a volume of 56,416 shares changing hands. The stock had previously closed at $27.96.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wall Street Zen upgraded Quantinuum from a "sell" rating to a "hold" rating in a report on Saturday, November 7th. Weiss Ratings assumed coverage on Quantinuum in a research note on Monday, August 31st. They issued a "sell (d)" rating on the stock. Yorkville Ives started coverage on Quantinuum in a research report on Monday, October 5th. They issued an "outperform" rating and a $60.00 target price on the stock. JPMorgan Chase & Co. cut their price target on Quantinuum from $97.00 to $80.00 and set an "overweight" rating for the company in a research note on Friday, November 6th. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $155.00 price target on shares of Quantinuum in a research note on Thursday, October 22nd. Fourteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Quantinuum currently has an average rating of "Moderate Buy" and a consensus target price of $80.21.

Check Out Our Latest Stock Report on QNT

Quantinuum Stock Up 1.3%

The firm has a market cap of $7.45 billion and a price-to-earnings ratio of -37.75. The company has a 50 day moving average price of $40.99.

Quantinuum (NASDAQ:QNT - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.99) by $0.70. The business had revenue of $9.05 million during the quarter. As a group, analysts forecast that Quantinuum Inc. will post -3.70 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Quantinuum

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Atreides Management LP raised its stake in Quantinuum by 0.9% during the 3rd quarter. Atreides Management LP now owns 40,225 shares of the company's stock valued at $1,933,000 after purchasing an additional 372 shares during the last quarter. Elequin Capital LP grew its position in Quantinuum by 65.9% in the 3rd quarter. Elequin Capital LP now owns 1,656 shares of the company's stock worth $80,000 after purchasing an additional 658 shares during the last quarter. CoreCap Advisors LLC bought a new position in shares of Quantinuum during the 3rd quarter worth about $32,000. Fifth Third Bancorp increased its holdings in shares of Quantinuum by 1,530.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company's stock worth $49,000 after purchasing an additional 964 shares during the period. Finally, IFP Advisors Inc raised its position in shares of Quantinuum by 1,150.0% during the third quarter. IFP Advisors Inc now owns 1,250 shares of the company's stock valued at $60,000 after buying an additional 1,150 shares during the last quarter.

About Quantinuum

(Get Free Report)

Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security. The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantinuum Right Now?

Before you consider Quantinuum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantinuum wasn't on the list.

While Quantinuum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines